Abstract The deer tick transmits nearly half of the known tick-borne pathogens in the United States, and its expanding geographic range increases the risk of
Lyme disease is the most common vector-borne infectious disease in the United States, in part because a vaccine against it is not currently available for
Valneva SE (“Valneva”), a specialty vaccine company focused on prevention of diseases with major unmet needs, today announced positive initial results for its first Phase